Multimorbidity and out-of-pocket expenditure on medicines: a systematic review

Background Multimorbidity, the presence of two or more non-communicable diseases (NCD), is a costly and complex challenge for health systems globally. Patients with NCDs incur high levels of out-of-pocket expenditure (OOPE), often on medicines, but the literature on the association between OOPE on medicines and multimorbidity has not been examined systematically. Methods A systematic review was conducted via searching medical and economics databases including Ovid Medline, EMBASE, EconLit, Cochrane Library and the WHO Global Health Library from year 2000 to 2016. Study quality was assessed using Newcastle-Ottawa Scale. PROSPERO: CRD42016053538. Findings 14 articles met inclusion criteria. Findings indicated that multimorbidity was associated with higher OOPE on medicines. When number of NCDs increased from 0 to 1, 2 and ≥3, annual OOPE on medicines increased by an average of 2.7 times, 5.2 times and 10.1 times, respectively. When number of NCDs increased from 0 to 1, 2, ≥2 and ≥3, individuals spent a median of 0.36% (IQR 0.15%–0.51%), 1.15% (IQR 0.62%–1.64%), 1.41% (IQR 0.86%–2.15%), 2.42% (IQR 2.05%–2.64%) and 2.63% (IQR 1.56%–4.13%) of mean annual household net adjusted disposable income per capita, respectively, on annual OOPE on medicines. More multimorbidities were associated with higher OOPE on medicines as a proportion of total healthcare expenditures by patients. Some evidence suggested that the elderly and low-income groups were most vulnerable to higher OOPE on medicines. With the same number of NCDs, certain combinations of NCDs yielded higher medicine OOPE. Non-adherence to medicines was a coping strategy for OOPE on medicines. Conclusion Multimorbidity of NCDs is increasingly costly to healthcare systems and OOPE on medicines can severely compromise financial protection and universal health coverage. It is crucial to recognise the need for better equity and financial protection, and policymakers should consider health system financial options, cost sharing policies and service patterns for those with NCD multimorbidities.

[1]  A. Stang.  Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses , 2010, European Journal of Epidemiology.

[2]  E. Lee,et al.  Living arrangements, chronic diseases, and prescription drug expenditures among Korean elderly: vulnerability to potential medication underuse , 2014, BMC Public Health.

[3]  M. Tonelli,et al.  Self-reported financial barriers to care among patients with cardiovascular-related chronic conditions. , 2014, Health reports.

[4]  Wenke Hwang,et al.  Rising out-of-pocket spending for chronic conditions: a ten-year trend. , 2009, Health affairs.

[5]  M. Tonelli,et al.  Out-of-pocket spending on drugs and pharmaceutical products and cost-related prescription non-adherence among Canadians with chronic disease. , 2016, Health reports.

[6]  R. Atun,et al.  Impact of Noncommunicable Disease Multimorbidity on Healthcare Utilisation and Out-Of-Pocket Expenditures in Middle-Income Countries: Cross Sectional Analysis , 2015, PloS one.

[7]  D. Dror,et al.  Cost of Illness: Evidence from a Study in Five Resource-Poor Locations in India , 2008, The Indian journal of medical research.

[8]  Matthew Perri,et al.  Potentially Inappropriate Medication Use and Healthcare Expenditures in the US Community-Dwelling Elderly , 2007, Medical care.

[9]  D. Ross-Degnan,et al.  Access to care and medicines, burden of health care expenditures, and risk protection: results from the World Health Survey. , 2011, Health policy.

[10]  Heather Angier,et al.  Insurance + access not equal to health care: typology of barriers to health care access for low-income families. , 2007, Annals of family medicine.

[11]  P. Tugwell,et al.  The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses , 2014 .

[12]  G. Anderson,et al.  Out-of-pocket medical spending for care of chronic conditions. , 2001, Health affairs.

[13]  S. Crystal,et al.  Total and out-of-pocket expenditures for prescription drugs among older persons. , 2003, The Gerontologist.

[14]  O. Franco,et al.  The global impact of non-communicable diseases on households and impoverishment: a systematic review , 2015, European Journal of Epidemiology.

[15]  Martin Fortin,et al.  Prevalence of Multimorbidity Among Adults Seen in Family Practice , 2005, The Annals of Family Medicine.

[16]  I. Wilson,et al.  Prescription drug coverage and seniors: findings from a 2003 national survey. , 2005, Health affairs.

[17]  Heather Angier,et al.  Insurance + Access ≠ Health Care: Typology of Barriers to Health Care Access for Low-Income Families , 2007, The Annals of Family Medicine.

[18]  I. Bygbjerg,et al.  Double Burden of Noncommunicable and Infectious Diseases in Developing Countries , 2012, Science.

[19]  S. Riedel-Heller,et al.  Review: Health Care Utilization and Costs of Elderly Persons With Multiple Chronic Conditions , 2011, Medical care research and review : MCRR.

[20]  K. Thorpe,et al.  Out-Of-Pocket Prescription Costs Under A Typical Silver Plan Are Twice As High As They Are In The Average Employer Plan. , 2015, Health affairs.

[21]  Michele Tarsilla.  Cochrane Handbook for Systematic Reviews of Interventions , 2010, Journal of MultiDisciplinary Evaluation.

[22]  O. Franco,et al.  The global impact of non-communicable diseases on healthcare spending and national income: a systematic review , 2015, European Journal of Epidemiology.

[23]  Haejoo Chung,et al.  Prescription Drug Use Among Adults With Chronic Conditions in South Korea , 2016, Asia-Pacific journal of public health.

[24]  Website Oecd,et al.  OECD Better Life Index , 2015 .

[25]  E. Roughead,et al.  Impact of cost of medicines for chronic conditions on low income households in Australia , 2013, Journal of health services research & policy.

[26]  Jennifer Prah Ruger,et al.  Out-of-Pocket Healthcare Spending by the Poor and Chronically Ill in the Republic of Korea , 2007, American journal of public health.

[27]  T. Fahey,et al.  Managing patients with multimorbidity in primary care , 2015, BMJ : British Medical Journal.

[28]  Young-Ho Jung,et al.  Out-of-pocket Medication Expenditure Burden of Elderly Koreans with Chronic Conditions , 2015 .

[29]  Dana P Goldman,et al.  Prescription drug cost sharing: associations with medication and medical utilization and spending and health. , 2007, JAMA.

[30]  Till Bärnighausen,et al.  The global economic burden of diabetes in adults aged 20-79 years: a cost-of-illness study. , 2017, The lancet. Diabetes & endocrinology.

[31]  S. Agrawal,et al.  Non communicable disease multimorbidity and associated health care utilization and expenditures in India: cross-sectional study , 2014, BMC Health Services Research.

[32]  J. Haas,et al.  How the new medicare drug benefit could affect vulnerable populations. , 2006, Health affairs.

[33]  D. Evans,et al.  The financial burden from non-communicable diseases in low- and middle-income countries: a literature review , 2013, Health Research Policy and Systems.

[34]  S. Crystal,et al.  Out-of-pocket health care costs among older Americans. , 2000, The journals of gerontology. Series B, Psychological sciences and social sciences.

[35]  J. Higgins,et al.  Cochrane Handbook for Systematic Reviews of Interventions , 2010, International Coaching Psychology Review.

[36]  B. Hanratty,et al.  Socioeconomic variation in the financial consequences of ill health for older people with chronic diseases: a systematic review. , 2013, Maturitas.

[37]  Martin McKee,et al.  Priority actions for the non-communicable disease crisis , 2011, The Lancet.